Companies: 49,246 Total Market Cap: 132596284745423.86

Gulf Pharmaceutical Industries P.S.C.

ADX-JULPHAR
Pharmaceutical Preparations
Rank #14652
Market Cap 430.09 M
Volume 2.19 M
Price 0.37
Change (%) 0.72%
Country or region United Arab Emirates United Arab Emirates

Gulf Pharmaceutical Industries P.S.C.'s latest marketcap:

430.09 M

As of 05/20/2025, Gulf Pharmaceutical Industries P.S.C.'s market capitalization has reached $430.09 M. According to our data, Gulf Pharmaceutical Industries P.S.C. is the 14652th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 430.09 M
Revenue (ttm) 362.76 M
Net Income (ttm) 49.89 M
Shares Out 1.16 B
EPS (ttm) 0.04
Forward PE 17.13
Ex-Dividend Date n/a
Earnings Date 05/09/2025
Market Cap Chart
Data Updated: 05/20/2025

Gulf Pharmaceutical Industries P.S.C.'s yearly market capitalization.

Gulf Pharmaceutical Industries P.S.C. has seen its market value grow from AED1.54 B to AED1.58 B since 2020, representing a total increase of 3.01% and an annual compound growth rate (CAGR) of 0.68%.
Date Market Cap Change (%)
05/20/2025 AED1.58 B 3.08%
12/31/2024 AED1.50 B 69.05%
12/29/2023 AED888.37 M -33.71%
12/30/2022 AED1.34 B -36.96%
12/30/2021 AED2.13 B 38.35%
12/31/2020 AED1.54 B

Company Profile

About Gulf Pharmaceutical Industries P.S.C.

Gulf Pharmaceutical Industries P.S.C. (Julphar) is a leading pharmaceutical company that manufactures and distributes a wide range of medicines, drugs, and healthcare products. Established in 1980 and headquartered in Ras al-Khaimah, UAE, the company operates across the GCC and internationally.

Business Segments

  • Manufacturing: Produces pharmaceutical and medical compounds.
  • Planet: Focuses on retail and distribution.
  • Investments: Engages in commercial and healthcare ventures.
  • Others: Includes logistics, facilities management, and medical equipment trading.

Product Portfolio

The company offers a diverse range of medicines, including:

  • Generic drugs for pain, inflammation, and antiviral treatments
  • Cardiovascular, respiratory, and CNS medications
  • Vitamins, supplements, and dermatology products
  • Diabetes care solutions, including insulin and glucose monitoring systems
  • Specialized treatments for gynecology, urology, and gastrointestinal health

Additional Services

Julphar also provides:

  • Wholesale and retail distribution of pharmaceuticals and cosmetics
  • Healthcare facility management and hospital operations
  • Medical equipment trading
Frequently Asked Questions

As of 05/20/2025, Gulf Pharmaceutical Industries P.S.C. (including the parent company, if applicable) has an estimated market capitalization of $430.09 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Gulf Pharmaceutical Industries P.S.C. global market capitalization ranking is approximately 14652 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region United Arab Emirates
Founded 1980
IPO Date n/a
Employees 2,400
CEO Basel Nimer Ziyadeh
Sector
Industry Pharmaceutical Preparations
Address Airport Road
Ras al-Khaimah
United Arab Emirates
Website https://www.julphar.net
People Also Watch
Ipsen S.A.
138.26 0.71%
Krka, d. d.
209.83 0.71%
BUD-RICHTER
29.12 0.71%
Hugel
245.27 0.71%